Novel hybrid biomimetic macroporous composites with tuned biodegradability, improved osteointegration and anticancer properties for bone tissue regeneration (HyBioComBone) Abstract
Article Sidebar
Published:
Mar 29, 2024
Keywords:
Large bone defects, interpenetrating network, hydrogels, bioglasses, calcium phosphates, extracellular vesicles
Main Article Content
Abstract
The treatment of large bone defects (LBDs) represents a major challenge in clinical orthopedics. Patients with LBDs caused by trauma, infections, or tissue resections due to cancer, often undergo multiple surgeries with long recovery times leading to deteriorated life quality and increased healthcare costs. The project HyBioComBone aims to develop novel biomimetic macroporous composites with multifunctional properties for bone repair, regeneration, and cancer treatment.
Article Details
How to Cite
[1]
Đorđe . Veljović, “Novel hybrid biomimetic macroporous composites with tuned biodegradability, improved osteointegration and anticancer properties for bone tissue regeneration (HyBioComBone): Abstract”, Hem Ind, vol. 78, no. 1S, p. 51, Mar. 2024, Accessed: Nov. 25, 2024. [Online]. Available: https://www.ache-pub.org.rs/index.php/HemInd/article/view/1297
Section
Biomaterials for orthopedic and dental applications
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors grant to the Publisher the following rights to the manuscript, including any supplemental material, and any parts, extracts or elements thereof:
- the right to reproduce and distribute the Manuscript in printed form, including print-on-demand;
- the right to produce prepublications, reprints, and special editions of the Manuscript;
- the right to translate the Manuscript into other languages;
- the right to reproduce the Manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these reproductions;
- the right to reproduce and distribute the Manuscript electronically or optically on any and all data carriers or storage media – especially in machine readable/digitalized form on data carriers such as hard drive, CD-Rom, DVD, Blu-ray Disc (BD), Mini-Disk, data tape – and the right to reproduce and distribute the Article via these data carriers;
- the right to store the Manuscript in databases, including online databases, and the right of transmission of the Manuscript in all technical systems and modes;
- the right to make the Manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the internet, other online services, or via internal or external networks.
How to Cite
[1]
Đorđe . Veljović, “Novel hybrid biomimetic macroporous composites with tuned biodegradability, improved osteointegration and anticancer properties for bone tissue regeneration (HyBioComBone): Abstract”, Hem Ind, vol. 78, no. 1S, p. 51, Mar. 2024, Accessed: Nov. 25, 2024. [Online]. Available: https://www.ache-pub.org.rs/index.php/HemInd/article/view/1297
Funding data
-
Science Fund of the Republic of Serbia
Grant numbers 7470
References
-